5-(1 H -[1,2,4]Triazol-3-ylsulfanyl)-furan-2-carbaldehyde, 95.0%, 1g

Ethyl 2-cyclohexylideneacetate, 95.0%, 25g

(S)-3-(4-benzylphenoxy)pyrrolidine hydrochloride, 98%, 500mg

3-(Methylsulfinyl)propan-1-amine, 95%, 250mg

(E)-2-Methyl-5-(2-nitrovinyl)thiazole, 98%, 2.5g

2-Chloro-6-(trifluoromethyl)benzylamine, 5g

N-(3-(4-METHYLPIPERAZIN-1-YL)PHENYL)-8-(4-(METHYLSULFONYL)PHENYL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-AMINE, 95%, 25mg

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 0.50 µm, 1 Piece(s)

4-(3-Pyridyl)-1H-1,2,3-triazole-5-carbonitrile, 95.0%, 2g

2,3',4'-Trichlorobenzophenone, 97.0%, 1g

2-Amino-4-(3-pyridinyl)-pyrimidine, 95.0%, 1g

2-Ethynyl-4-methoxypyridine, 500mg

(2E)-1-(2,4-dimethylphenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 10g